NUREXONE BIOLOGIC INC (NRX.CA) Stock Balance Sheet
TSX-V:NRX - TSX Venture Exchange - CA67059R1091 - Common Stock - Currency: CAD
| MRQ (2024-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 0.00 | 10.00K | 0.00 | |||
| Cash Equivalents | 2.52M | 2.46M | N/A | N/A | N/A | |||
| Receivables | 259.00K | 52.00K | 10.00K | 10.00K | 30.00K | |||
| Other Current Assets | 41.00K | 177.00K | 1.68M | N/A | 0.00 | |||
| Total Current Assets | 2.82M | 2.69M | 1.69M | 10.00K | 30.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 791.00K | 102.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 791.00K | 102.00K | 0.00 | 0.00 | 0.00 | |||
| TOTAL ASSETS | 3.61M | 2.79M | 1.69M | 10.00K | 30.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 172.00K | 456.00K | N/A | N/A | N/A | |||
| Accounts Payable | N/A | N/A | 110.00K | 70.00K | 70.00K | |||
| Other Current Liabilities | 263.00K | 127.00K | 1.77M | 10.00K | 0.00 | |||
| Total Current Liabilities | 435.00K | 583.00K | 1.88M | 80.00K | 70.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 31.00K | 20.00K | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 220.00K | 95.00K | N/A | N/A | N/A | |||
| Total Non-Current Liabilities | 251.00K | 115.00K | 0.00 | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 686.00K | 698.00K | 1.88M | 80.00K | 70.00K | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -14.75M | -9.08M | -1.16M | -1.02M | -980.00K | |||
| Additional Paid In Capital | 17.78M | 11.25M | N/A | N/A | N/A | |||
| Common Shares | N/A | N/A | 960.00K | 950.00K | 930.00K | |||
| Other Shareholders' Equity | -109.00K | -73.00K | N/A | N/A | N/A | |||
| Shares Outstanding | 70.52M | 42.86M | 2.54M | 2.54M | 2.54M | |||
| Tangible Book Value per Share | 0.04 | 0.05 | -0.08 | -0.03 | -0.02 | |||
| Total Shareholders' Equity | 2.93M | 2.10M | -200.00K | -70.00K | -40.00K | |||
| TOTAL LIABILITIES AND EQUITY | 3.61M | 2.79M | 1.69M | 10.00K | 30.00K | |||
| Statistics | ||||||||
| Debt/Equity | 0.01 | 0.01 | N/A | N/A | N/A | |||
| Current Ratio | 6.49 | 4.62 | 0.90 | 0.13 | 0.43 | |||
| Return On Assets (ROA) | -117.16% | -292.38% | -7.69% | -200.00% | -200.00% | |||
| Return On Equity (ROE) | -144.60% | -389.74% | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.28